Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

1
 

• Peptide Therapeutics Market - Global Industry
  Analysis
• Bharat Book Bureau

2
Summary

• Peptide therapeutics is currently offering a
  new commercial potential to pharmaceuticals and
  biotechnology industry. To exploit this emerging
  market, large pharmaceutical and biotechnological
  firms are actively investing in development of
  newer peptides for various applications and are
  also opting for newer technologies for syntheses
  of these peptides. Cancer is the leading cause of
  death globally according to the WHO (World
  Health Organization), around 12.7 million new
  cancer cases occurred in the year 2008. About 7
  million people die from cancer every year and it
  is estimated that there will be more than 16
  million new cancer cases every year by 2020. With
  rise in cancer patients and metabolic diseases
  like diabetes, there has been a push in growth
  for peptide molecules since chemotherapy, which
  is the major mode of treatment for cancer, is
  facing major challenges due to its inability to
  deliver the correct amount of drug directly. In
  addition, it affects the normal cells in the
  body. 

3
Continue

• Likewise, peptide application in various
  other treatments has opened a promising avenue
  for future growth of this market. New routes of
  peptide administration are being investigated
  however the parenteral route continues to
  dominate this market and accounted for a share of
  almost 86 of the entire market. Similarly, the
  technology market is ruled by LPPS (long phase
  peptide syntheses) and is anticipated to decline
  owing to huge demand for solid phase peptide
  syntheses and hybrid syntheses.This report
  analyzes the peptide therapeutics market by types
  of applications (cancer, metabolic, neurological
  diseases and others), route of administration, by
  types (innovative and generic), by API
  therapeutics market (in-house vs. CMO), by
  peptide therapeutics, and technology. Each of
  these markets is analyzed by studying the current
  and future market scenario, with estimation for
  the period 2010 2018 in terms of value in USD
  million.

4
Continue

• The peptide therapeutics market is also
  segmented based on geography into North America,
  Europe, Asia and rest of the world (RoW) regions.
  The market for all these geographical regions is
  provided in the report in terms of revenue. The
  report provides complete analysis of the factors
  responsible for driving and restraining the
  global peptide therapeutics market. Competitive
  landscape is provided with market players
  profiled with attributes like company overview,
  financial overview, business strategies, product
  portfolio and recent developments. Market shares
  in 2011 for the key players and CMO players are
  provided and recommendations to accentuate market
  shares and ensure sustainability are provided in
  this reportKey market players profiled in this
  report are Eli Lilly, Roche, Amylin,
  Novo-Nordisk, Ipsen and others. While CMOs major
  players profiled are Bachem, Lonza, Peptisyntha,
  Polypeptide group and others.

5
Continue

• Peptide Therapeutics Market, by
  ApplicationsCancerMetabolicCardiovascularDerma
  tologyAnti-InfectionNeurologyGastro
  IntestinalRenal RespiratoryPainOthersPeptide
  Therapeutics Market, by Route of
  AdministrationParenteralOralPulmonaryMucosal

6
Continue

• OthersPeptide Therapeutics Market, by
  TypesInnovativeGenericsPeptide Therapeutics
  Market, by API Peptide In-HouseCMO (Contract
  Manufacturing Organization)Peptide Therapeutics
  by TechnologyLiquid Phase Peptide Synthesis
  (LPPS)Solid Phase Peptide Synthesis
  (SPPS)Hybrid Peptide Therapeutics Market, by
  GeographyNorth AmericaEuropeAsiaRoW 

7
Table of Contents

• Chapter 1 Introduction1.1 Report
  description1.2 Market segmentation1.3 Scope of
  the report1.4 Research methodology1.5
  AssumptionsChapter 2 Executive Summary2.1
  Global peptide therapeutics market revenues, 2010
  2018 (USD Million)2.1.1 Global peptide
  therapeutics market revenues, by region, 2010 -
  2018 (USD Million)2.1.2 Global API peptide
  therapeutics market, 2011 (USD Million)2.1.3
  Global peptide therapeutics market, by route of
  administration, 2011 2018 ()

8
Continue

• Chapter 3 Global Peptide Therapeutics
  Market Dynamics3.1 Overview3.2 Drivers3.2.1
  Increase in cancer patient population to propel
  the growth of new peptides3.2.2 Rise in
  metabolic disorders to escalate the growth of
  peptides market3.2.3 Rise in RD pipeline of
  peptide drugs is expected to bring considerable
  growth in coming years3.2.3.1 Global peptide
  therapeutics trials growth, 1970 - 20113.2.4
  Technological enhancement has boosted the growth
  of the market with radical reduction in total
  production cost of peptides3.3 Restraints
  challenges3.3.1 Increasing complexity of
  peptides is a huge challenge for
  manufacturers3.3.2 Lack of regulatory standards
  hampering the growth of the market3.3.3 Matching
  equipments with customer requirements is a major
  challenge for API peptide manufacturers

9
For More Information You Can Visit-

• http//www.bharatbook.com/healthcare-market-r
  esearch-reports/peptide-therapeutics-market-global
  -industry-analysis-size-share-growth-trends-and-fo
  recast-2012-2018.html
• Or visit us at
• Bharat Book
  Bureau Phone
  91 22 27810772, 27810773
  Toll Free No for USA/Canada
  1-866-279-8368
  E-mail info_at_bharatbook.com
  Website www.bharatbook.com
  Twitter
  https//twitter.com/BharatBook
  Blog http//www.bharatbook.com/marke
  t-reports-blog/